about
Mutation of SALL2 causes recessive ocular coloboma in humans and miceARNT2 mutation causes hypopituitarism, post-natal microcephaly, visual and renal anomaliesIdentification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemiaThe impact of phenocopy on the genetic analysis of complex traits.Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorderFailure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients.Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.Human longevity and 11p15.5: a study in 1321 centenariansCharacterisation and validation of insertions and deletions in 173 patient exomesParaoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin.Complexity of anti-immunosenescence strategies in humans.Genes, ageing and longevity in humans: problems, advantages and perspectives.Role of mitochondrial DNA in longevity, aging and age-related diseases in humans: a reappraisal.PON1 is a longevity gene: results of a meta-analysis.Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies.Identification and validation of loss of function variants in clinical contextsParkDB: a Parkinson's disease gene expression databaseAn APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.Marie Curie fellowships unraveled an interview with Theodosius Lennon, director directorate T, DG Research, European Commission.Human models of aging and longevityGenotype of inflammatory cytokines in limbal stem cell graft in Italian patientsYoung scientist: Italian biotechnologists organizeEstimating the functional impact of INDELs in transcription factor binding sites: a genome-wide landscapeThe Young European Biotech Network (YEBN)A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism
P50
Q24319044-CA9412F8-B5A3-4BCB-A478-69DDF1B68C26Q24324164-00A8BEDF-C5E8-42E5-97A8-1814FCBBA8C9Q28943326-077761B4-9B1B-4EF5-825B-1703F0D4495FQ33649844-5DB1C481-C56D-4EBF-9439-3200F5327429Q33649844-6AB5277D-4F2C-4E41-9794-1051DA1EE287Q33707718-94AECB24-0CFD-4BFC-B84A-6756649C06D6Q34121245-931A1ABD-8815-41C5-9286-E9E174816199Q34298428-164EA096-1D8A-4FA9-8BD9-32FB66F7F821Q34327320-13E297FC-5B13-40AA-AF87-0961038ECB1BQ34516375-4089EC68-7F0A-4331-8AFF-F7A24FA8938BQ35875743-4416B085-A097-4DF4-864E-A8509DA7F935Q36616598-A6DE3499-9B48-4574-AD1F-831D1881B4F6Q36647435-84C66179-3856-4F96-BBFE-7C3C6F09ED78Q37385268-A3E81BCF-41DB-4823-8B47-EF0F42628B39Q37450192-79494035-9E12-4F9A-B6AA-4D8AE4FBE0A8Q37730157-96B243E0-D222-44B1-8C19-3E9ED9FBD5D0Q41902164-C053E0A1-3C4E-4700-91F2-2E55C5CFD3B9Q42183671-D09C12D1-24A2-4805-AA52-A2AF5F2786B7Q43643907-3769E6A7-E850-4379-A444-F51FACFC334DQ48488052-520D9CFB-807D-4800-8EC2-175C7DDF62BEQ56992524-B86B1915-C77C-4C94-9123-DBF09A351B70Q56999800-6FD17F29-C0B4-4ADE-A183-DB32AC250A6FQ57002948-343BD6AD-1342-464C-B7D4-6BAE866A7BC9Q60622214-D80DC40C-3629-4649-B344-71537F23E522Q81338543-54BA34D1-812D-49AD-BB0B-BCC0A55ED0E2Q81358257-8EABCD52-E9AC-4AE1-9E06-6B516FEE8219
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesco Lescai
@ast
Francesco Lescai
@en
Francesco Lescai
@es
Francesco Lescai
@nl
type
label
Francesco Lescai
@ast
Francesco Lescai
@en
Francesco Lescai
@es
Francesco Lescai
@nl
prefLabel
Francesco Lescai
@ast
Francesco Lescai
@en
Francesco Lescai
@es
Francesco Lescai
@nl
P106
P1153
8614142900
P21
P31
P496
0000-0002-6399-9101